Literature DB >> 17468237

Role of thrombopoietin in mast cell differentiation.

Anna Rita Migliaccio1, Rosa Alba Rana, Alessandro M Vannucchi, Francesco A Manzoli.   

Abstract

Mast cells are important elements of the body response to foreign antigens, being those represented either by small molecules (allergic response) or harbored by foreign microorganisms (response to parasite infection). These cells derive from hematopoietic stem/progenitor cells present in the marrow. However, in contrast with most of the other hematopoietic lineages, mast cells do not differentiate in the marrow but in highly vascularized extramedullary sites, such as the skin or the gut. Mast cell differentiation in the marrow is activated as part of the body response to parasites. We will review here the mast cell differentiation pathway and what is known of its major intrinsic and extrinsic control mechanisms. It will also be described that thrombopoietin, the ligand for the Mpl receptor, in addition to its pivotal rule in the control of thrombocytopoiesis and of hematopoietic stem/progenitor cell proliferation, exerts a regulatory function in mast cell differentiation. Some of the possible implications of this newly described biological activity of thrombopoietin will be discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17468237     DOI: 10.1196/annals.1392.024

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  6 in total

1.  Pathological interactions between hematopoietic stem cells and their niche revealed by mouse models of primary myelofibrosis.

Authors:  Lilian Varricchio; Annalisa Mancini; Anna Rita Migliaccio
Journal:  Expert Rev Hematol       Date:  2009-06-01       Impact factor: 2.929

2.  Thrombopoietin inhibits murine mast cell differentiation.

Authors:  Fabrizio Martelli; Barbara Ghinassi; Rodolfo Lorenzini; Alessandro M Vannucchi; Rosa Alba Rana; Mitsuo Nishikawa; Sandra Partamian; Giovanni Migliaccio; Anna Rita Migliaccio
Journal:  Stem Cells       Date:  2008-02-14       Impact factor: 6.277

3.  Gene therapy of MPL deficiency: challenging balance between leukemia and pancytopenia.

Authors:  Daniel C Wicke; Johann Meyer; Guntram Buesche; Dirk Heckl; Hans Kreipe; Zhixiong Li; Karl H Welte; Matthias Ballmaier; Christopher Baum; Ute Modlich
Journal:  Mol Ther       Date:  2009-10-20       Impact factor: 11.454

4.  Increased differentiation of dermal mast cells in mice lacking the Mpl gene.

Authors:  Barbara Ghinassi; Maria Zingariello; Fabrizio Martelli; Rodolfo Lorenzini; Alessandro M Vannucchi; Rosa Alba Rana; Mitsuo Nishikawa; Giovanni Migliaccio; John Mascarenhas; Anna Rita Migliaccio
Journal:  Stem Cells Dev       Date:  2009-09       Impact factor: 3.272

5.  Levels of thrombopoietin in aqueous humor of patients with noninfectious acute anterior uveitis.

Authors:  José-Juan Mondejar; David Salom; Salvador Garcia-Delpech; Manuel Diaz-Llopis
Journal:  Clin Ophthalmol       Date:  2015-07-13

6.  VEGF controls lung Th2 inflammation via the miR-1-Mpl (myeloproliferative leukemia virus oncogene)-P-selectin axis.

Authors:  Seyedtaghi Takyar; Hema Vasavada; Jian-ge Zhang; Farida Ahangari; Naiqian Niu; Qing Liu; Chun Geun Lee; Lauren Cohn; Jack A Elias
Journal:  J Exp Med       Date:  2013-09-16       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.